Finance

Lists
041830:KOSDAQ
InBody Co Ltd
â‚©57,600.00
-1.20%
(-700.00) 1D
Sep 11, 3:30:09 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 041830...
Open
â‚©58,100
High
â‚©59,400
Low
â‚©57,300
Mkt. cap
776.50B
Avg. vol.
125.11K
Volume
0.00
Dividend
1.04%
Quarterly dividend
â‚©150
Ex-dividend date
Mar 30, 2026
P/E ratio
18.54
52-wk high
â‚©73,500
52-wk low
â‚©26,200
EPS
â‚©3,107
Shares outstanding
13.48M
No. of employees
285
Open
â‚©58,100
High
â‚©59,400
Low
â‚©57,300
Mkt. cap
776.50B
Avg. vol.
125.11K
Volume
0.00
Dividend
1.04%
Quarterly dividend
â‚©150
Ex-dividend date
Mar 30, 2026
P/E ratio
18.54
52-wk high
â‚©73,500
52-wk low
â‚©26,200
EPS
â‚©3,107
Shares outstanding
13.48M
No. of employees
285
About InBody Co Ltd
CEOKichul Cha
Employees285
FoundedMay 15, 1996
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
59.80B
62.40B
68.44B
73.25B
Cost of goods sold
15.37B
13.65B
17.17B
14.56B
Cost of revenue
15.37B
13.65B
17.17B
14.56B
Research and development expenses
2.73B
3.31B
2.75B
2.84B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.33B
32.84B
33.01B
35.52B
Operating expense
34.62B
39.23B
38.25B
40.95B
Total operating expenses
49.99B
52.87B
55.42B
55.51B
Operating income
9.81B
9.52B
13.02B
17.74B
Other non operating income
17.43M
-186.36M
101.94M
221.58M
EBT including unusual items
11.77B
9.85B
17.93B
21.29B
EBT excluding unusual items
11.80B
9.94B
17.84B
21.32B
Income tax expense
2.37B
3.50B
1.63B
6.76B
Effective tax rate
20.17%
35.50%
9.10%
31.74%
Other operating expenses
668.50M
843.69M
638.94M
678.74M
Net income
9.64B
6.41B
16.33B
14.16B
Net profit margin
16.12%
10.28%
23.86%
19.33%
Earnings per share
-
-
-
-
Interest and investment income
743.09M
833.65M
905.44M
966.90M
Interest expense
-145.77M
-176.26M
-103.59M
-88.20M
Net interest expenses
597.31M
657.39M
801.85M
878.70M
Depreciation and amortization charges
1.44B
1.83B
1.65B
1.68B
EBITDA
11.87B
12.05B
15.33B
20.07B
Gain or loss from assets sale
-5.13M
-30.63M
-25.26M
-16.24M
AI content may include mistakes. Learn more
Google apps